BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 17587882)

  • 21. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
    Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
    Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructural characteristics of bone marrow in patients with hematological disease: a study of 13 cases.
    Ru YX; Zhao SX; Liu EB; Yang QY; Liu JH; Pang TX; Chen HS
    Ultrastruct Pathol; 2007; 31(5):327-32. PubMed ID: 17963181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

  • 24. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
    Bock O
    Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult leukaemia--making the diagnosis.
    De Boer R; Grigg A
    Aust Fam Physician; 1994 Aug; 23(8):1508-11, 1514-5, 1518. PubMed ID: 7980150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
    Winfield DA; Polacarz SV
    J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
    [No Abstract]   [Full Text] [Related]  

  • 27. Myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML) and chronic myeloproliferative disorder (CMPD) in cats.
    Breuer W; Hermanns W; Thiele J
    J Comp Pathol; 1999 Oct; 121(3):203-16. PubMed ID: 10486157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of atypical chronic myeloid leukemia regarded as MDS with myeloproliferative features.
    Tohda S; Koyama N; Tanaka M; Kida Y; Murakami N; Nara N
    Acta Haematol; 1998; 100(4):191-4. PubMed ID: 9973641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J; Kvasnicka HM; Vardiman J
    Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescence in situ hybridization reveals closely correlated results in cytological and histological specimens of hematological neoplasias compared to conventional cytogenetics.
    Gerr H; Gadzicki D; Kreipe H; Schlegelberger B; Wilkens L
    Pathobiology; 2006; 73(6):271-9. PubMed ID: 17374964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemia and myelomatosis.
    Catovsky D
    Cancer Chemother Biol Response Modif; 1987; 9():134-64. PubMed ID: 3079401
    [No Abstract]   [Full Text] [Related]  

  • 32. Current world literature.
    Curr Opin Hematol; 2011 Mar; 18(2):124-31. PubMed ID: 21307671
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diagnosis of adult leukemia].
    Kuraishi Y; Takasaki N; Ogawa K
    Gan No Rinsho; 1989 Jan; Spec No():560-9. PubMed ID: 2915500
    [No Abstract]   [Full Text] [Related]  

  • 34. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
    Găman M; Vlădăreanu AM; Radesi S
    Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive bone marrow diagnosis on a single aspiration sample. Plastic sections and cell suspensions for enzyme and immunohisto- and cytochemistry.
    van de Sandt MM; Herman CJ; Lindeman J
    Pathol Annu; 1987; 22 Pt 1():67-82. PubMed ID: 3554122
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study.
    Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Guàrdia R; Marcos-Gragera R
    Leuk Lymphoma; 2015 Apr; 56(4):896-902. PubMed ID: 25058372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic myeloid leukemia. Diagnosis, evolution and prognosis, treatment].
    Reiffers J; Montastruc M; Bilhou-Nabera C
    Rev Prat; 1990 Sep; 40(20):1879-85. PubMed ID: 1699264
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage.
    Chaidos A; Kanfer E; Apperley JF
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):125-54. PubMed ID: 17448953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.
    Santana-Davila R; Holtan SG; Dewald GW; Ketterling RP; Knudson RA; Hanson CA; Steensma DP; Tefferi A
    Leuk Res; 2008 Mar; 32(3):407-11. PubMed ID: 17707907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.